Rahul Sharma, PhD, recieves grant from LaunchPad: the Diabetes Biomedical Innovation Fund
Rahul Sharma, PhD, has received a grant from LaunchPad: the Diabetes Biomedical Innovation Fund.
The LaunchPad program is a translational research fund supporting collaborative research projects that propose innovative and viable solutions to curing, treating or diagnosing Diabetes. The LaunchPad program is possible due to a generous gift from Paul and Diane Manning.
PI: Rahul Sharma, PhD
Title: “Novel Hybrid Cytokine for Therapy of Type-1Diabetes”
Award Dates: 05/01/2013-04/30/2014
We have developed novel proprietary reagents that are anti-inflammatory. The goal of this study is to evaluate the efficacy of these immuno-modulatory reagents for therapy of Type-1Diabetes using mouse models. Following the successful completion of these studies, the therapeutic reagents will be employed for future translational studies against autoimmune and inflammatory diseases.